Tag: Emblaveo

Over 1.14 million deaths were attributed to bacterial antimicrobial resistance (AMR) in 2021, underscoring the urgent need for new therapies to address the question, **What is the new FDA approved antibiotic?**. The newest approvals offer targeted weapons against increasingly defiant pathogens, providing critical new options for healthcare professionals.

Antimicrobial resistance (AMR) contributed to over a million deaths worldwide in 2021, underscoring the urgent need for novel treatments. So, what is the new antibiotic in 2025 that offers hope against these superbugs? Several important approvals and pipeline developments mark the year.